|
| 37059069 | Cancer neuroscience: State of the field, emerging directions. | Cell | 2023 |
| 36107223 | MRI-guided laser interstitial thermal therapy for deep-seated gliomas in children with neurofibromatosis type 1: report of two cases. | Childs Nerv Syst | 2023 |
| 37662971 | Putting a stop to nonsense: Revisiting gene correction therapy for neurofibromatosis type 1. | | 2023 |
| 37738646 | Optimizing preclinical pediatric low-grade glioma models for meaningful clinical translation. | Neuro Oncol | 2023 |
| 37733448 | A paracrine circuit of IL-1β/IL-1R1 between myeloid and tumor cells drives genotype-dependent glioblastoma progression. | | 2023 |
| 36840626 | Clinical, histological, and molecular features of gliomas in adults with neurofibromatosis type 1. | Neuro Oncol | 2023 |
| 37465080 | Neurofibromatosis Type 1-Associated Optic Pathway Gliomas: Current Challenges and Future Prospects. | | 2023 |
| 36890585 | Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic. | | 2023 |
| 37012245 | Monocyte depletion enhances neutrophil influx and proneural to mesenchymal transition in glioblastoma. | | 2023 |
| 36693322 | Neurons as stromal drivers of nervous system cancer formation and progression. | | 2023 |
| 35325210 | T lymphocytes as dynamic regulators of glioma pathobiology. | Neuro-Oncology | 2022 |
| 35589737 | Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1. | Nature Communications | 2022 |
| 35561805 | Predictors of Patient Return to a Tertiary Neurofibromatosis Subspecialty Clinic. | Journal of Pediatrics | 2022 |
| 35868305 | Can the "female protective effect" liability threshold model explain sex differences in autism spectrum disorder? | Neuron | 2022 |
| 36327895 | Microglia states and nomenclature: A field at its crossroads. | Neuron | 2022 |
| 35986378 | Human induced pluripotent stem cell engineering establishes a humanized mouse platform for pediatric low-grade glioma modeling. | Acta Neuropathol Commun | 2022 |
| 35674741 | Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation. | Genet Med | 2022 |
| 37435433 | Neurofibromatosis-1 Gene Mutational Profiles Differ Between Syndromic Disease and Sporadic Cancers. | | 2022 |
| 35188187 | RAS and beyond: the many faces of the neurofibromatosis type 1 protein. | DMM Disease Models and Mechanisms | 2022 |
| 35187488 | Immune deconvolution and temporal mapping identifies stromal targets and developmental intervals for abrogating murine low-grade optic glioma formation. | Neuro-Oncology Advances | 2022 |
| 35018469 | Risk factors for treatment-refractory and relapsed optic pathway glioma in children with neurofibromatosis type 1. | Neuro Oncol | 2022 |
| 35199037 | Generation of human induced pluripotent stem cell-derived cerebral organoids for cellular and molecular characterization. | STAR Protocols | 2022 |
| 34880260 | Asthma reduces glioma formation by T cell decorin-mediated inhibition of microglia. | Nature Communications | 2021 |
| 31838937 | Cognition, ADHD Symptoms, and Functional Impairment in Children and Adolescents With Neurofibromatosis Type 1. | J Atten Disord | 2021 |
| 34233200 | Patient-derived iPSC-cerebral organoid modeling of the 17q11.2 microdeletion syndrome establishes CRLF3 as a critical regulator of neurogenesis. | Cell Reports | 2021 |
| 33585982 | Integrated molecular and clinical analysis of low-grade gliomas in children with neurofibromatosis type 1 (NF1). | Acta Neuropathol | 2021 |
| 34286276 | Immune cell analysis of pilocytic astrocytomas reveals sexually dimorphic brain region-specific differences in T-cell content. | Neurooncol Adv | 2021 |
| 34012067 | Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation. | Genet Med | 2021 |
| 33743598 | Shared developmental gait disruptions across two mouse models of neurodevelopmental disorders. | Journal of Neurodevelopmental Disorders | 2021 |
| 33884301 | Familial Lipomas Without Classic Neurofibromatosis-1 Caused by a Missense Germline NF1 Mutation. | Neurology: Genetics | 2021 |
| 34040258 | NF1 mutation drives neuronal activity-dependent initiation of optic glioma. | Nature | 2021 |
| 33441399 | SRF Is Required for Maintenance of Astrocytes in Non-Reactive State in the Mammalian Brain. | eNeuro | 2021 |
| 34131743 | Reimagining pilocytic astrocytomas in the context of pediatric low-grade gliomas. | Neuro Oncol | 2021 |
| 32815557 | Autism in neurofibromatosis type 1: misuse of covariance to dismiss autistic trait burden. | Dev Med Child Neurol | 2021 |
| 33080011 | Temporal, spatial, and genetic constraints contribute to the patterning and penetrance of murine neurofibromatosis-1 optic glioma. | Neuro-Oncology | 2021 |
| 33336845 | Visual outcomes following everolimus targeted therapy for neurofibromatosis type 1-associated optic pathway gliomas in children. | Pediatr Blood Cancer | 2021 |
| 33108355 | Humanized neurofibroma model from induced pluripotent stem cells delineates tumor pathogenesis and developmental origins. | Journal of Clinical Investigation | 2021 |
| 32603552 | Global microRNA profiling identified miR-10b-5p as a regulator of neurofibromatosis 1 (NF1)-glioma migration. | Neuropathol Appl Neurobiol | 2021 |
| 34987881 | Predictive Modeling for Clinical Features Associated With Neurofibromatosis Type 1. | Neurol Clin Pract | 2021 |
| 34625582 | BRAF mutations may identify a clinically distinct subset of glioblastoma. | Sci Rep | 2021 |
| 33221469 | Visual field outcomes in children treated for neurofibromatosis type 1-associated optic pathway gliomas: a multicenter retrospective study. | J AAPOS | 2020 |
| 31915069 | Correction to: Comprehensive gene expression meta-analysis identifies signature genes that distinguish microglia from peripheral monocytes/macrophages in health and glioma. | Acta Neuropathol Commun | 2020 |
| 32243842 | Human iPSC-Derived Neurons and Cerebral Organoids Establish Differential Effects of Germline NF1 Gene Mutations. | Stem Cell Reports | 2020 |
| 32358581 | Midkine activation of CD8 T cells establishes a neuron-immune-cancer axis responsible for low-grade glioma growth. | Nature Communications | 2020 |
| 32302564 | Roadmap for the Emerging Field of Cancer Neuroscience. | Cell | 2020 |
| 32300062 | Nonoptic pathway tumors in children with neurofibromatosis type 1. | Neurology | 2020 |
| 32236425 | A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1-associated pediatric low-grade glioma: a Neurofibromatosis Clinical Trials Consortium study. | Neuro Oncol | 2020 |
| 32055852 | Implications of new understandings of gliomas in children and adults with NF1: report of a consensus conference. | Neuro Oncol | 2020 |
| 32098655 | Erratum to "KIAA1549-BRAF Expression Establishes a Permissive Tumor Microenvironment Through NFκB-Mediated CCL2 Production" [Neoplasia, Volume: 21, Issue:1, (2019) 52-60]. | Neoplasia | 2020 |
| 32030651 | The Sociobiology of Brain Tumors. | Advances in Experimental Medicine and Biology | 2020 |